Diagnosing peanut allergy in a child with severe atopic dermatitis

Published On: 17 Feb, 2023 4:25 PM | Updated On: 14 May, 2024 8:13 PM

Diagnosing peanut allergy in a child with severe atopic dermatitis

Children with atopic dermatitis (AD) pose a higher risk of peanut allergy. However, these children may have more raised sensitization measures, including serum IgE (sIgE) and skin prick testing (SPT) at baseline, without necessarily having a clinical allergy. A recent report describes a case of a child who, despite having AD and significantly elevated sIgE and SPT to peanut, passed an oral food challenge (OFC).

The study described a case of a 16-month-old patient who presented for evaluation of severe eczema and food allergy. He familiarized peanuts in the form of Bamba at home, which overlapped with an atopic dermatitis flare, although cutaneous symptoms did not appear immediately. The patient received an intensive skin care regimen with clinical improvement. His SPT to peanut came positive with a wheal of 7 × 5 mm. His total sIgE was 10,229 kU/L, sIgE to peanut was 39.7 kUA/L, and sIgE to Ara h 2 was 1.72 kUA/L. A 5-dose OFC to peanut butter came negative. His parents received instructions to incorporate peanut butter into his diet regularly.

Given the significance of early exposure in clinical allergy prevention, it may be worth using an OFC for children without a clear history of immediate type 1 hypersensitivity reactions to peanuts, even with elevated sensitization measures. Before OFC, close attention to skin care is also essential so that a cutaneous reaction to the culprit food is not confused with a background eczema flare that may have happened without food exposure.

Nevid M, Rabinovitch N. A LEAP FORWARD IN EVALUATION OF PEANUT ALLERGY IN A CHILD WITH SEVERE ATOPIC DERMATITIS. Annals of Allergy, Asthma & Immunology. 2022;129(5): S148. https://doi.org/10.1016/j.anai.2022.08.935.

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks